CN Stock MarketDetailed Quotes

Chengdu Easton Biopharmaceuticals (688513)

Watchlist
  • 62.45
  • +1.12+1.83%
Trading Mar 26 11:09 CST
11.02BMarket Cap45.68P/E (TTM)

Chengdu Easton Biopharmaceuticals (688513) Revenue Breakdown Overview

By Product

Currency:CNY
2025/H1
Stock NameRevenueRatio
Preparation sales515.38M78.75%
Bulk drug sales60.34M9.22%
技术服务及转让44.47M6.79%
CMO/CDMO26.25M4.01%
Other8.01M1.22%

By Industry

Currency:CNY
2024/FY
Stock NameRevenueRatio
Pharmaceutical manufacturing industry1.35B99.86%
Other business1.84M0.14%

By Country/Region

Currency:CNY
2025/H1
Stock NameRevenueRatio
East China region240.49M36.75%
Southwest area125.35M19.15%
North China98.78M15.09%
South China78.2M11.95%
Central China49.97M7.64%
Northeast area26.82M4.10%
Northwest region22.98M3.51%
Overseas region11.85M1.81%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
Recently, the prospect of a ceasefire negotiation between the US and Iran has been dominating market sentiment. Previously, news that the US Show More